Vertex Pharmaceuticals Incorporated(VRTX)
NASDAQ

Stock Price Forecast & Analyst Targets

$557.96
1.21 (0.22%)

VRTX Stock Forecast Chart

VRTX Stock Forecast 2026 – Price Prediction, Target & Outlook

Vertex Pharmaceuticals Incorporated (VRTX) stock forecast for 2026 indicates a wide range of potential outcomes based on analyst targets and model-driven predictions. As of September 2026, VRTX stock shows a dynamic price pattern in the short term, with price targets reflecting potential future volatility across bull, base, and bear scenarios over the next 12 months.

VRTX Bull Case Price Target (2027)

$883.96

In a bullish scenario, VRTX stock could reach this maximum projection over the next 12 months, driven by upside momentum and outperforming technical indicators.

VRTX Base Forecast (2027)

$722.87

The base case model predicts this median target, assuming VRTX maintains steady growth, consistent volume profiles, and normalized market conditions.

VRTX Bear Case Price Target (2027)

$561.77

In a broader market downturn or bearish correction, VRTX shares could potentially trace back to this support level over the forecast horizon.

Confidence:67.8% (High)
Signal:Short-Term Bullish
6M + 12M
Historical
Forecast Avg
Max Range
Min Range
Prophet Model Forecast

Vertex Pharmaceuticals Incorporated Analyst Consensus & Target Price

Wall Street sentiment and price target analysis for VRTX

STRONG BUY

Consensus based on 25 analysts

High conviction buy - significant upside potential

Mean Target Price
$563.12+0.9%
High Target$672.00
Low Target$350.00
Number of Opinions25

Price Target Analysis

Target Range: $350.00 - $672.00

Current vs Mean Target: +0.9%

Analyst Coverage: 25 firms tracking

Key Considerations

• Target prices reflect 12-month outlook

• Based on fundamental analysis and DCF models

• Consider market volatility in timing decisions

VRTX stock Price Projections & Forecast Models

Data-driven price predictions based on technical analysis and analyst consensus for VRTX

Model-Based Predictions

$571.70
1-Month Target
+2.5%
$722.87
1-Year Target
+29.6%

Analyst Consensus

$563.12
Analyst Mean Target
+0.9% vs Current

Model Methodology & Confidence

Technical Indicators:

  • • Moving averages (SMA 20, 50, 200)
  • • RSI and momentum oscillators
  • • Support/resistance levels
  • • Volume-price analysis

Fundamental Factors:

  • • Earnings growth projections
  • • Revenue trend analysis
  • • Valuation multiple normalization
  • • Sector performance correlation

Scenario Analysis Chart

Vertex Pharmaceuticals Incorporated (VRTX) Detailed Price Forecast

Algorithmic projections for monthly price bands and momentum signals

According to current predictive modeling and historical volatility analysis, the company is projected to fluctuate between a potential low of $532.18 and a high of $883.96 over the forecast horizon. These estimates blend near-term technical momentum with fundamental analyst consensus targets.

PeriodMin PriceAvg PriceMax PricePotential ROISignal
Oct 2026534.92571.70608.48+2.5%
Hold
Nov 2026532.18585.44638.71+4.9%
Hold
Dec 2026532.42599.19665.95+7.4%
Buy
Jan 2027534.07612.93691.79+9.9%
Buy
Feb 2027536.52626.67716.82+12.3%
Buy
Mar 2027539.50640.41741.33+14.8%
Buy
Apr 2027542.81654.16765.50+17.2%
Buy
May 2027546.37667.90789.43+19.7%
Buy
Jun 2027550.09681.64813.20+22.2%
Buy
Jul 2027553.92695.38836.85+24.6%
Buy
Aug 2027557.82709.13860.43+27.1%
Buy
Sep 2027561.77722.87883.96+29.6%
Buy

Source methodology: Model forecasts are independent estimates blending technical signals with analyst consensus data. Actual market prices are subject to volatility and macroeconomic factors. All projections are for informational purposes only.